Published in Medicine and Law Weekly, September 1st, 2006
By expanding its direct distribution initiative to include both soft and cervical spinal bone implants, Clearant has increased its addressable market from $100 million or more per year (for cervical spinal implants) to $350 million or more per year (for both soft tissue and cervical spinal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.